William (Bill) Hyun, PhD, serves as a Venture Partner at Genoa Ventures. See sector focus and contact routes.
William (Bill) Hyun, PhD, serves as a Venture Partner at Genoa Ventures, bringing over 25 years of expertise in life sciences and technology development from his prior role directing major academic core facilities at the University of California San Francisco. His investment thesis targets early-stage companies where biology converges with technology, focusing on sectors such as research tools, molecular diagnostics, synthetic biology, and industrial biology within the United States. Hyun invests in early-stage life sciences ventures and frequently acts as a co-founder or board member rather than just a passive investor. Notable portfolio companies include Mission Bio, Scribe Biosciences, Akadeum Biosciences, and Fluent BioSciences, where he serves as a board member and co-founder. He holds board positions at Slingshot Biosciences and Newbridge Media while also serving on scientific advisory boards for Fibralign, Intabio, and CellFe. Hyun’s distinctive point of view centers on advancing biotechnology through genomics, cellular heterogeneity, and cell sorting, reflecting his deep background in laboratory medicine and cytometry.
This profile is part of the StartupFundraising firm database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in San Francisco Bay Area.
Investors like William (Bill) Hyun · Full investor directory · Investor access · Company funding database